tasquinimod (ABR-215050) / Active Biotech, Ipsen  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
tasquinimod (ABR-215050) / Active Biotech, Ipsen
NCT01048203: A Single Dose Metabolism and Mass Balance Study of 14C-ABR-215050 in Healthy Subjects

Completed
1
6
Europe
ABR-215050, tasquinimod
Active Biotech AB
Healthy
03/09
03/09
NCT04405167: Tasquinimod for the Treatment of Relapsed or Refractory Myeloma

Recruiting
1
34
US
Tasquinimod, IRd chemotherapy, Ixazomib, Lenalidomide, Dexamethasone
University of Pennsylvania, Active Biotech AB
Multiple Myeloma
07/24
07/25

Download Options